Published Date: 17 Jun 2024
Also in TTHealthWatch: cancers subsequent to CAR-T therapy
Read Full NewsSwiss generic drugmaker Sandoz filed a draft anti-dumping complaint with the European Commission over Chinese imports of the antibiotic ingredient amoxicillin.
Dr Bishal Gyawali explores why lowering the bar for drug approvals is a fallacy and why asking for better evidence is a sign of patient advocacy, not an attack on innovation.
Quantitative T2* MRI is feasible and reproducible for detecting microvasculopathy-related iron deposition in the soft tissues of the fingers.
An observational study suggests that bone mineral density may serve as a marker of systemic health.
Patients with autoimmune diseases who experience ocular inflammation while on adalimumab have an increased risk of developing antibodies against the drug, according to a recent retrospective study.
The World Health Organization has recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola.
Experts warn that concentrated herbal and dietary supplements are increasingly linked to severe liver injury, while regulation remains limited.
1.
Never in a million years did I think I'd have to limit my chemotherapy.
2.
According to JAMA, statin use may increase cancer-related survival in breast cancer patients.
3.
These Athletes Weren't Doping. Their Genes Made It Look Like They Did.
4.
Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice
5.
Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists
1.
Oncology Treatment: Innovations, Education, and Clinical Practice Insights
2.
Treating Methemoglobinemia: What You Need to Know Now!
3.
Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers
4.
Bone-on-a-Chip Systems: A Revolutionary Approach to Modeling Hematological Cancers
5.
Beyond the Biopsy: The Evolving Landscape of Prostate Cancer Management
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A New Era in Managing Cancer-Associated Thrombosis
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation